1. Home
  2. ONTF vs CRBP Comparison

ONTF vs CRBP Comparison

Compare ONTF & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$6.05

Market Cap

212.8M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.70

Market Cap

202.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTF
CRBP
Founded
1998
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.8M
202.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ONTF
CRBP
Price
$6.05
$9.70
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$6.00
$50.29
AVG Volume (30 Days)
210.9K
501.1K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$141,348,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$4.64
52 Week High
$7.04
$20.56

Technical Indicators

Market Signals
Indicator
ONTF
CRBP
Relative Strength Index (RSI) 63.79 33.28
Support Level $5.78 $10.10
Resistance Level $6.13 $10.82
Average True Range (ATR) 0.19 0.75
MACD 0.05 -0.02
Stochastic Oscillator 92.39 7.01

Price Performance

Historical Comparison
ONTF
CRBP

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: